Highbridge Capital Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-36,513
| Closed | -$701K | – | 1069 |
|
|
2017
Q1 | $701K | Buy |
36,513
+8,317
| +29% | +$160K | 0.01% | 614 |
|
|
2016
Q4 | $470K | Buy |
28,196
+1,704
| +6% | +$28.4K | 0.01% | 663 |
|
|
2016
Q3 | $545K | Sell |
26,492
-92,983
| -78% | -$1.91M | 0.01% | 648 |
|
|
2016
Q2 | $3.66M | Buy |
+119,475
| New | +$3.66M | 0.06% | 277 |
|
|
2015
Q1 | – | Sell |
-6,751
| Closed | -$230K | – | 972 |
|
|
2014
Q4 | $230K | Buy |
+6,751
| New | +$230K | ﹤0.01% | 657 |
|
|
2013
Q4 | – | Sell |
-1,035,508
| Closed | -$24.3M | – | 867 |
|
|
2013
Q3 | $24.3M | Buy |
1,035,508
+285,315
| +38% | +$6.71M | 0.26% | 108 |
|
|
2013
Q2 | $20.2M | Buy |
+750,193
| New | +$20.2M | 0.2% | 119 |
|